MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2018 International Congress

    Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report

    S. El-Jaafary, A. Sabbah, S. Ahmed (Cairo, Egypt)

    Objective: To be acquainted with the extrapyramidal symptoms developed during the course of central pontine myelinolysis. To emphasize the importance of neuroimaging in the diagnosis…
  • 2018 International Congress

    Atypical presentation of PANK2 mutation: A case report

    M. Sousa, R. Varela, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: To describe an atypical presentation of a PANK2 mutation. Background: PKAN (Pantothenate-Kinase-Associated Neurodegeneration) is the most common NBIA (Neurodegeneration with brain iron accumulation) disorder,…
  • 2018 International Congress

    Siblings with a PRKRA (DYT16) Mutation and Startle Myoclonus

    L. Wiblin, M. Baker, M. Lai, R. Horvath, N. Warren (Newcastle upon Tyne, United Kingdom)

    Objective: To characterize and expand the phenotype of a family from North-East England with DYT16. Background: DYT16 is an autosomal recessive disease associated with mutations…
  • 2018 International Congress

    Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp

    J. Park, E. Shamim, O. Panyakaew, P. Mathew, C. Toro, J. Sackett, B. Karp, C. Lungu, K. Alter, B. Hodsdon, M. Villegas, T. Wu, O. Ahmad, P. Srivanitchapoom, S. Auh, M. (Goyang, Republic of Korea)

    Objective: We aimed to compare the effects of botulinum toxin (BoNT) therapy alone with a combination of BoNT and occupational therapy on patients with writer’s…
  • 2018 International Congress

    Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders

    T. Gendre, G. Carle, F. Mesrati, M. Houot, B. Degos, B. Garcin (Créteil, France)

    Objective: To compare the quality of life (QoL) and psychiatric comorbidities of patients with functional (psychogenic) movement disorders (FMD) and patients with organic movements disorders…
  • 2018 International Congress

    Cervical dystonia in Modigliani’s paintings: The clue was the sensory trick

    J.C. Martinez Castrillo, A. Alonso Canovas, P.J. Garcia (Madrid, Spain)

    Objective: To confirm that Jeanne Hebuterne, Modigliani's muse, suffered from cervical dystonia Background: Amedeo Modigliani was one of the most outstanding painters of the XX…
  • 2018 International Congress

    Characterizing Bulbar Dysfunction in X-Linked Dystonia-Parkinsonism (XDP): A Pilot Study

    J. de Guzman, B. Perry, C. Go, J. Green, N. Sharma (Boston, MA, USA)

    Objective: This study aims to characterize bulbar motor impairments in patients with X-linked XDP and to identify clinical correlates for prediction of aspiration. Background: X-linked…
  • 2018 International Congress

    Does ‘DYT23’ exist? Report of a second family with adult- onset focal dystonia and a CACNA1AB mutation – causative or coincidental?

    P. Agarwal, M. Desai, S. Ravat (Mumbai, India)

    Objective: To describe clinical and genetic findings in a patient with focal adult-onset primary cranial dystonia and chorea, and a mutation in CACNA1B (also referred…
  • 2018 International Congress

    Difference in sleep disorders among Parkinson’s disease, cervical dystonia and patients with depression

    S. Tomic, D. Degmecic, S. Milanovic, F. Gjoni, I. Dumencic, Z. Popovic, T. Gilman Kuric (Osijek, Croatia)

    Objective: Aim of this study was to evaluate frequency and characteristics of sleep disorders among patients with Parkinson disease (PD), cervical dystonia (CD) and depression.…
  • 2018 International Congress

    Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism

    J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann (Luebeck, Germany)

    Objective: To investigate whether alterations of cortical thickness correspond to cognitive dysfunction in XDP patients. Background: X-linked dystonia-parkinsonism (XDP) is a severe, hereditary movement disorder…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 48
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley